<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9201927</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1281</journal-id>
<journal-id journal-id-type="nlm-ta">Dev Dyn</journal-id>
<journal-id journal-id-type="iso-abbrev">Dev. Dyn.</journal-id>
<journal-title-group>
<journal-title>Developmental dynamics : an official publication of the American Association of Anatomists</journal-title>
</journal-title-group>
<issn pub-type="ppub">1058-8388</issn>
<issn pub-type="epub">1097-0177</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31070828</article-id>
<article-id pub-id-type="pmc">6995669</article-id>
<article-id pub-id-type="doi">10.1002/dvdy.60</article-id>
<article-id pub-id-type="manuscript">NIHMS1068577</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>New frontiers in modeling Tuberous Sclerosis with human stem cell-derived neurons and brain organoids</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Blair</surname>
<given-names>John D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bateup</surname>
<given-names>Helen S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720 USA.</aff>
<aff id="A2"><label>2</label>Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720 USA.</aff>
<aff id="A3"><label>3</label>Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.</aff>
<author-notes>
<corresp id="CR1">Corresponding author: Helen S. Bateup, Ph.D., University of California, Berkeley, 291 Life Sciences Addition, Berkeley, CA 94720-3200, <email>bateup@berkeley.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>249</volume>
<issue>1</issue>
<fpage>46</fpage>
<lpage>55</lpage>
<!--elocation-id from pubmed: 10.1002/dvdy.60-->
<abstract id="ABS1">
<p id="P1">Recent advances in human stem cell and genome engineering have enabled the generation of genetically-defined human cellular models for brain disorders. These models can be established from a patient’s own cells and can be genetically engineered to generate isogenic, controlled systems for mechanistic studies. Given the challenges of obtaining and working with primary human brain tissue, these models fill a critical gap in our understanding of normal and abnormal human brain development and provide an important complement to animal models. Recently, there has been major progress in modeling the neuropathophysiology of the canonical “mTORopathy” Tuberous Sclerosis Complex (TSC) with such approaches. Studies using two- and three-dimensional cultures of human neurons and glia have provided new insights into how mutations in the <italic>TSC1</italic> and <italic>TSC2</italic> genes impact human neural development and function. Here we discuss recent progress in human stem cell-based modeling of TSC and highlight challenges and opportunities for further efforts in this area.</p>
</abstract>
<kwd-group>
<kwd>Tuberous Sclerosis Complex</kwd>
<kwd>TSC1</kwd>
<kwd>TSC2</kwd>
<kwd>mTOR</kwd>
<kwd>cortical tuber</kwd>
<kwd>human pluripotent stem cells</kwd>
<kwd>brain organoids</kwd>
<kwd>neurons</kwd>
<kwd>astrocytes</kwd>
<kwd>disease modeling</kwd>
<kwd>CRISPR/Cas9</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>